Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Did COVID-19 impact Positive Airway Pressure adherence in 2020? A cross-sectional study of 8477 patients with sleep apnea.

Tytuł:
Did COVID-19 impact Positive Airway Pressure adherence in 2020? A cross-sectional study of 8477 patients with sleep apnea.
Autorzy:
Bertelli F; Department of Medical Information, Montpellier University Hospital, IDESP, UMR 5149, Montpellier University, 34090, Montpellier, France.; Groupe Adène, rue de Chambert, 34080, Montpellier, France.
Suehs CM; Department of Medical Information, Montpellier University Hospital, IDESP, UMR 5149, Montpellier University, 34090, Montpellier, France.; Department of Respiratory Diseases, Univ Montpellier, CHU Montpellier, 371, Avenue Doyen Giraud, 34295, Montpellier Cedex 5, France.
Mallet JP; Department of Respiratory Diseases, Univ Montpellier, CHU Montpellier, 371, Avenue Doyen Giraud, 34295, Montpellier Cedex 5, France.; PhyMedExp, CNRS, INSERM, Univ Montpellier, CHU Montpellier, Montpellier, France.
Court-Fortune I; Department of Respiratory Diseases, CHU Saint Etienne, 25, boulevard Pasteur, 42055, Saint-Étienne Cedex 2, France.
Gagnadoux F; Department of Respiratory and Sleep Medicine, Angers University Hospital, INSERM U1063, SOPAM, Angers University, Angers, France.
Borel JC; Inserm U1042, HP2 (Hypoxia PhysioPathology), Laboratory Centre Hospitalier Universitaire Grenoble Alpes, Grenoble Alps, University, Grenoble, France.
Gaubert O; Groupe Adène, rue de Chambert, 34080, Montpellier, France.
Molinari N; Department of Medical Information, Montpellier University Hospital, IDESP, UMR 5149, Montpellier University, 34090, Montpellier, France.
Bourdin A; Department of Respiratory Diseases, Univ Montpellier, CHU Montpellier, 371, Avenue Doyen Giraud, 34295, Montpellier Cedex 5, France.; PhyMedExp, CNRS, INSERM, Univ Montpellier, CHU Montpellier, Montpellier, France.
Jaffuel D; Groupe Adène, rue de Chambert, 34080, Montpellier, France. .; Department of Respiratory Diseases, Univ Montpellier, CHU Montpellier, 371, Avenue Doyen Giraud, 34295, Montpellier Cedex 5, France. .; PhyMedExp, CNRS, INSERM, Univ Montpellier, CHU Montpellier, Montpellier, France. .
Źródło:
Respiratory research [Respir Res] 2022 Mar 04; Vol. 23 (1), pp. 46. Date of Electronic Publication: 2022 Mar 04.
Typ publikacji:
Journal Article; Multicenter Study
Język:
English
Imprint Name(s):
Publication: 2001- : London : BioMed Central Ltd.
Original Publication: London : Current Science Ltd., c2000-
MeSH Terms:
Pandemics*
Treatment Adherence and Compliance*
COVID-19/*epidemiology
Continuous Positive Airway Pressure/*methods
Sleep Apnea Syndromes/*therapy
Aged ; Comorbidity ; Cross-Sectional Studies ; Female ; France/epidemiology ; Humans ; Incidence ; Male ; Middle Aged ; Polysomnography ; Retrospective Studies ; Sleep Apnea Syndromes/epidemiology ; Treatment Outcome
References:
Thorax. 2020 May;75(5):367. (PMID: 32273335)
Chronobiol Int. 2020 Aug;37(8):1181-1190. (PMID: 32757673)
Sleep. 2007 Jun;30(6):711-9. (PMID: 17580592)
Sleep Med. 2021 Aug;84:98-106. (PMID: 34144451)
J Sleep Res. 2021 Oct;30(5):e13368. (PMID: 33955081)
Eur Respir J. 2020 Jul 30;56(1):. (PMID: 32430426)
J Clin Sleep Med. 2020 Nov 15;16(11):1917-1920. (PMID: 32780011)
Sleep. 2021 Feb 12;44(2):. (PMID: 32918076)
Am J Respir Crit Care Med. 2020 Jun 15;201(12):P28-P29. (PMID: 32281886)
JAMA. 2017 Jul 11;318(2):156-166. (PMID: 28697252)
Arch Bronconeumol (Engl Ed). 2020 Dec;56(12):818-819. (PMID: 32773300)
Thorax. 2020 May;75(5):368. (PMID: 32273336)
J Clin Sleep Med. 2019 Feb 15;15(2):301-334. (PMID: 30736888)
Sleep Med. 2021 Apr;80:126-133. (PMID: 33596526)
Eur J Public Health. 2021 Feb 1;31(1):23-30. (PMID: 33169169)
Eur Respir J. 2021 Mar 4;57(3):. (PMID: 33214202)
Contributed Indexing:
Keywords: And adherence; COVID 19; CPAP; Sleep Apnea
Molecular Sequence:
ClinicalTrials.gov NCT04775966
Entry Date(s):
Date Created: 20220305 Date Completed: 20220321 Latest Revision: 20220321
Update Code:
20240105
PubMed Central ID:
PMC8894547
DOI:
10.1186/s12931-022-01969-z
PMID:
35246109
Czasopismo naukowe
Background: Whether the COVID-19 pandemic impacts Positive Airway Pressure (PAP) adherence over the long-term is unknown and only preliminary short-term data have been reported.
Methods: With the aim of describing the impact of the first and second waves of COVID-19 on PAP adherence during 2020 in France, we designed a cross-sectional study of Sleep-Apnea (SA)-patients under PAP telemonitoring. To examine PAP adherence in adult SA patients, we assessed de-identified data from a non-profit healthcare provider database during the period January 1, 2019 to December 31, 2020. Included patients met the following criteria: (i) PAP-treated for at least 4 months before January 1, 2019 and with continuous PAP during both 2019 and 2020; (ii) ≥ 360 daily PAP telemonitored data per year. For PAP adherence, data were collected using the PAP-software.
Results: 8477/10482 patients were finally included in the analysis [72.4% male, median age 70 years (IQ 25-75 : 61-77], 25.6% < 62 years old, initial Apnea-Hypopnea Index (AHI) of 41 (31-59)/h. Median PAP adherence was 7.21 (6.12-8.10) h/day in 2020 versus 7.12 (6.05-8.02) h/day in 2019, p < 0.001. The median difference in PAP adherence between the first 2020 lockdown and the corresponding 2019 weeks was 9.75 (CI 95% 8.75-10.75) min/day, p < 0.001. The median difference in PAP adherence between the second 2020 lockdown and the corresponding 2019 weeks was 5.00 (CI 95% 4.00-6.00) min/day, p < 0.001. If we consider the minimal clinically important difference of 30 min for PAP adherence, 30.4% and 26% of the patients increased their PAP adherence by at least 30 min during the first and second lockdowns respectively; 17.6% and 19.3% of the patients lowered their PAP adherence by at least 30 min in the first and second lockdowns, respectively.
Conclusion: During the first and second lockdowns, the COVID-19 pandemic had a clinically irrelevant effect on PAP adherence for the study population. Future studies are needed to describe COVID-19 pandemic impact on PAP adherence not only for long-term PAP-treated SA patients but also for incident cases. Trial registration The COVADENE study was registered on March 1st, 2021 on ClinicalTrials.gov (Identifier: NCT04775966).
(© 2022. The Author(s).)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies